Literature DB >> 11961302

NF-kappa B binding activity and cyclooxygenase-2 expression in persistent CCl(4)-treated rat liver injury.

Sang Hyun Kim1, Hyung Jun Chu, Dae Hwan Kang, Geun Am Song, Mong Cho, Ung Suk Yang, Hyon Jeen Kim, Hae Young Chung.   

Abstract

The involvement of NF-kappa B binding activity is known to be important in the mechanism of acute liver injury and in the induction of cyclooxygenase (COX-2). This study was performed to evaluate NF-kappa B binding activity and the expression of COX-2 in chronic liver injury induced by carbon tetrachloride (CCl(4)). Liver tissues from Sprague-Dawley rats were collected at 1, 3, 5, and 7th week after intraperitoneal injection of 0.1 mL of CCl(4)/100 g body weight twice a week. Reactive oxy-gen species (ROS) were measured in the postmitochondrial fraction by dichlorofluorescein formation with a fluorescent probe. An electrophoretic mobility shift assay was performed for NF-kappa B binding activity. Western blot was performed to measure the level of COX-1, COX-2, p65, p50, and I B proteins. ROS and NF-kappa B activity increased during the CCl4-induced chronic liver injury. The expression of nuclear p65 protein and p50 protein increased compared with that of the control, while the cytoplasmic I B protein decreased as the inflammation persisted. The expression of COX-2 in CCl(4)-treated rat liver increased compared with that of the control. It could be suggested that ROS produced by CCl(4) treatment increased NF-kappa B binding activity and thereby COX-2 expression, and these might be implicated in the progress of chronic liver damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961302      PMCID: PMC3054866          DOI: 10.3346/jkms.2002.17.2.193

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  7 in total

1.  Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.

Authors:  Memy H Hassan; Mohamed M Ghobara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-31       Impact factor: 3.000

Review 2.  Toll-Like Receptors Contribute to Sex Differences in Blood Pressure Regulation.

Authors:  Vanessa Dela Justina; Fernanda R Giachini; Jennifer C Sullivan; R Clinton Webb
Journal:  J Cardiovasc Pharmacol       Date:  2020-09       Impact factor: 3.105

3.  Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.

Authors:  Sura Wanessa Santos Rocha; Maria Eduarda Rocha de França; Gabriel Barros Rodrigues; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; André Filipe Pastor; Anne Gabrielle Vasconcelos Oliveira; Wilma Helena Oliveira; Rayana Leal Almeida Luna; Christina Alves Peixoto
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

4.  Protective Effects of Royal Jelly on Oxymetholone-Induced Liver Injury in Mice.

Authors:  Vahid Nejati; Ensieh Zahmatkesh; Mohammad Babaei
Journal:  Iran Biomed J       Date:  2016-05-14

5.  The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity.

Authors:  Hala Attia; Nouf Al-Rasheed; Raeesa Mohamad; Nawal Al-Rasheed; Maha Al-Amin
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

6.  Novel Antioxidant, Deethylated Ethoxyquin, Protects against Carbon Tetrachloride Induced Hepatotoxicity in Rats by Inhibiting NLRP3 Inflammasome Activation and Apoptosis.

Authors:  Igor Y Iskusnykh; Evgenii D Kryl'skii; Darya A Brazhnikova; Tatyana N Popova; Khidmet S Shikhaliev; Konstantin K Shulgin; Larisa V Matasova; Sergey S Popov; Dmitry A Zhaglin; Anastasia A Zakharova; Nelli R Popova; Nikolai Fattakhov
Journal:  Antioxidants (Basel)       Date:  2021-01-15

7.  Celecoxib in the treatment of orofacial pain and discomfort in rats subjected to a dental occlusal interference model.

Authors:  Andrea Whitehurst Ary Leitão; Marcela Maria Fontes Borges; Joyce Ohana de Lima Martins; Antônio Alexandre Coelho; Anna Clara Aragão Matos Carlos; Ana Paula Negreiros Nunes Alves; Paulo Goberlânio de Barros Silva; Fabrício Bitu Sousa
Journal:  Acta Cir Bras       Date:  2022-08-15       Impact factor: 1.564

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.